FDA wants to collect long-term data on pexidartinib's liver toxicity risks as part of a Risk Evaluation and Mitigation Strategy. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
